Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Correction: The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics.

Taft J, Bogunovic D.

J Immunol. 2019 Apr 15;202(8):2511. doi: 10.4049/jimmunol.1900253. Epub 2019 Mar 8. No abstract available.

PMID:
30850478
2.

The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics.

Taft J, Bogunovic D.

J Immunol. 2018 Dec 15;201(12):3479-3485. doi: 10.4049/jimmunol.1800764. Review. Erratum in: J Immunol. 2019 Apr 15;202(8):2511.

PMID:
30530500
3.

SAMHD1 deficient human monocytes autonomously trigger type I interferon.

Martinez-Lopez A, Martin-Fernandez M, Buta S, Kim B, Bogunovic D, Diaz-Griffero F.

Mol Immunol. 2018 Sep;101:450-460. doi: 10.1016/j.molimm.2018.08.005. Epub 2018 Aug 9.

PMID:
30099227
4.

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.

Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, Nelson AE, Loo K, Kumar R, Rosenblum MD, Alvarado MD, Wolf DM, Bogunovic D, Bhardwaj N, Daud AI, Ha PK, Ryan WR, Pollack JL, Samad B, Asthana S, Chan V, Krummel MF.

Nat Med. 2018 Aug;24(8):1178-1191. doi: 10.1038/s41591-018-0085-8. Epub 2018 Jun 25.

5.

ISG15: In Sickness and in Health.

Hermann M, Bogunovic D.

Trends Immunol. 2017 Feb;38(2):79-93. doi: 10.1016/j.it.2016.11.001. Epub 2016 Nov 22. Review.

PMID:
27887993
6.

Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.

Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, Kaisho T, Bogunovic D, Bhardwaj N, Krummel MF.

Cancer Cell. 2016 Aug 8;30(2):324-336. doi: 10.1016/j.ccell.2016.06.003. Epub 2016 Jul 14.

7.

Refractive index gratings in electro-optic polymer thin films.

Bogunovic D, Raymond SG, Janssens S, Clarke D, Bodley O, Ashforth S, Simpson MC, Quilty JW.

Appl Opt. 2016 Jun 10;55(17):4676-82. doi: 10.1364/AO.55.004676.

PMID:
27409025
8.

Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome.

Meuwissen ME, Schot R, Buta S, Oudesluijs G, Tinschert S, Speer SD, Li Z, van Unen L, Heijsman D, Goldmann T, Lequin MH, Kros JM, Stam W, Hermann M, Willemsen R, Brouwer RW, Van IJcken WF, Martin-Fernandez M, de Coo I, Dudink J, de Vries FA, Bertoli Avella A, Prinz M, Crow YJ, Verheijen FW, Pellegrini S, Bogunovic D, Mancini GM.

J Exp Med. 2016 Jun 27;213(7):1163-74. doi: 10.1084/jem.20151529. Epub 2016 Jun 20.

9.

ISG15 deficiency and increased viral resistance in humans but not mice.

Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, Rubino E, Gardner TJ, Wedeking T, Hermann M, Duehr J, Sanal O, Tezcan I, Mansouri N, Tabarsi P, Mansouri D, Francois-Newton V, Daussy CF, Rodriguez MR, Lenschow DJ, Freiberg AN, Tortorella D, Piehler J, Lee B, García-Sastre A, Pellegrini S, Bogunovic D.

Nat Commun. 2016 May 19;7:11496. doi: 10.1038/ncomms11496.

10.

Type I Interferons in Newborns-Neurotoxicity versus Antiviral Defense.

Bogunovic D.

MBio. 2016 May 17;7(3). pii: e00639-16. doi: 10.1128/mBio.00639-16.

11.

Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.

Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramírez-Alejo N, Kilic SS, El Baghdadi J, Nonoyama S, Mahdaviani SA, Ailal F, Bousfiha A, Mansouri D, Nievas E, Ma CS, Rao G, Bernasconi A, Sun Kuehn H, Niemela J, Stoddard J, Deveau P, Cobat A, El Azbaoui S, Sabri A, Lim CK, Sundin M, Avery DT, Halwani R, Grant AV, Boisson B, Bogunovic D, Itan Y, Moncada-Velez M, Martinez-Barricarte R, Migaud M, Deswarte C, Alsina L, Kotlarz D, Klein C, Muller-Fleckenstein I, Fleckenstein B, Cormier-Daire V, Rose-John S, Picard C, Hammarstrom L, Puel A, Al-Muhsen S, Abel L, Chaussabel D, Rosenzweig SD, Minegishi Y, Tangye SG, Bustamante J, Casanova JL, Boisson-Dupuis S.

J Exp Med. 2015 Sep 21;212(10):1641-62. doi: 10.1084/jem.20140280. Epub 2015 Aug 24.

12.

Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation.

Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, Volpi S, Li Z, Sanal O, Mansouri D, Tezcan I, Rice GI, Chen C, Mansouri N, Mahdaviani SA, Itan Y, Boisson B, Okada S, Zeng L, Wang X, Jiang H, Liu W, Han T, Liu D, Ma T, Wang B, Liu M, Liu JY, Wang QK, Yalnizoglu D, Radoshevich L, Uzé G, Gros P, Rozenberg F, Zhang SY, Jouanguy E, Bustamante J, García-Sastre A, Abel L, Lebon P, Notarangelo LD, Crow YJ, Boisson-Dupuis S, Casanova JL, Pellegrini S.

Nature. 2015 Jan 1;517(7532):89-93. doi: 10.1038/nature13801. Epub 2014 Oct 12.

13.

Pathogenesis of post-lyme disease symptoms.

Seligman SJ, Petzke MM, Bogunovic D.

Clin Infect Dis. 2014 Sep 1;59(5):747. doi: 10.1093/cid/ciu341. Epub 2014 May 7. No abstract available.

PMID:
24812298
14.

Partial IFN-γR2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation.

Moncada-Vélez M, Martinez-Barricarte R, Bogunovic D, Kong XF, Blancas-Galicia L, Tirpan C, Aksu G, Vincent QB, Boisson B, Itan Y, Ramírez-Alejo N, Okada S, Kreins AY, Bryant VL, Franco JL, Migaud M, Espinosa-Padilla S, Yamazaki-Nakashimada M, Espinosa-Rosales F, Kutukculer N, Abel L, Bustamante J, Vogt G, Casanova JL, Boisson-Dupuis S.

Blood. 2013 Oct 3;122(14):2390-401. doi: 10.1182/blood-2013-01-480814. Epub 2013 Aug 20. Erratum in: Blood. 2014 Mar 6;123(10):1622.

15.

ISG15: leading a double life as a secreted molecule.

Bogunovic D, Boisson-Dupuis S, Casanova JL.

Exp Mol Med. 2013 Apr 12;45:e18. doi: 10.1038/emm.2013.36. Review.

16.

Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.

Ott PA, Henry T, Baranda SJ, Frleta D, Manches O, Bogunovic D, Bhardwaj N.

Cancer Immunol Immunother. 2013 Apr;62(4):811-22. doi: 10.1007/s00262-012-1389-z. Epub 2013 Jan 10.

PMID:
23306863
17.

Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.

Kong XF, Vogt G, Itan Y, Macura-Biegun A, Szaflarska A, Kowalczyk D, Chapgier A, Abhyankar A, Furthner D, Djambas Khayat C, Okada S, Bryant VL, Bogunovic D, Kreins A, Moncada-Vélez M, Migaud M, Al-Ajaji S, Al-Muhsen S, Holland SM, Abel L, Picard C, Chaussabel D, Bustamante J, Casanova JL, Boisson-Dupuis S.

Hum Mol Genet. 2013 Feb 15;22(4):769-81. doi: 10.1093/hmg/dds484. Epub 2012 Nov 16.

18.

Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.

Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Israël L, Trevejo-Nunez G, Bogunovic D, Cepika AM, MacDuff D, Chrabieh M, Hubeau M, Bajolle F, Debré M, Mazzolari E, Vairo D, Agou F, Virgin HW, Bossuyt X, Rambaud C, Facchetti F, Bonnet D, Quartier P, Fournet JC, Pascual V, Chaussabel D, Notarangelo LD, Puel A, Israël A, Casanova JL, Picard C.

Nat Immunol. 2012 Dec;13(12):1178-86. doi: 10.1038/ni.2457. Epub 2012 Oct 28.

19.

Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency.

Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova JL.

Science. 2012 Sep 28;337(6102):1684-8. Epub 2012 Aug 2.

20.

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.

Bogunovic D, Manches O, Godefroy E, Yewdall A, Gallois A, Salazar AM, Marie I, Levy DE, Bhardwaj N.

Cancer Res. 2011 Aug 15;71(16):5467-76. doi: 10.1158/0008-5472.CAN-10-3988. Epub 2011 Jul 5.

21.

LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.

Feig JE, Pineda-Torra I, Sanson M, Bradley MN, Vengrenyuk Y, Bogunovic D, Gautier EL, Rubinstein D, Hong C, Liu J, Wu C, van Rooijen N, Bhardwaj N, Garabedian M, Tontonoz P, Fisher EA.

J Clin Invest. 2010 Dec;120(12):4415-24. doi: 10.1172/JCI38911.

22.

A novel form of human STAT1 deficiency impairing early but not late responses to interferons.

Kong XF, Ciancanelli M, Al-Hajjar S, Alsina L, Zumwalt T, Bustamante J, Feinberg J, Audry M, Prando C, Bryant V, Kreins A, Bogunovic D, Halwani R, Zhang XX, Abel L, Chaussabel D, Al-Muhsen S, Casanova JL, Boisson-Dupuis S.

Blood. 2010 Dec 23;116(26):5895-906. doi: 10.1182/blood-2010-04-280586. Epub 2010 Sep 14.

23.

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.

Bogunovic D, O'Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, Lonardi S, Zavadil J, Osman I, Bhardwaj N.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20429-34. doi: 10.1073/pnas.0905139106. Epub 2009 Nov 13.

24.

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.

Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9. doi: 10.1073/pnas.0808263106. Epub 2009 Feb 2.

25.

Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.

Minkis K, Kavanagh DG, Alter G, Bogunovic D, O'Neill D, Adams S, Pavlick A, Walker BD, Brockman MA, Gandhi RT, Bhardwaj N.

Cancer Res. 2008 Nov 15;68(22):9441-50. doi: 10.1158/0008-5472.CAN-08-0900.

26.

Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.

Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, O'Neill D, Yu YL, Spira J, Christos PJ, Zhou XK, Mazumdar M, Nanus DM, Liebes L, Bhardwaj N, Polsky D, Osman I.

J Transl Med. 2007 Jan 5;5:2.

27.

Nonparaxial scalar treatment of sinusoidal phase gratings.

Harvey JE, Krywonos A, Bogunovic D.

J Opt Soc Am A Opt Image Sci Vis. 2006 Apr;23(4):858-65.

PMID:
16604767
28.

Aberrations of diffracted wave fields: distortion.

Harvey JE, Bogunovic D, Krywonos A.

Appl Opt. 2003 Mar 1;42(7):1167-74.

PMID:
12638873
29.

Tolerance on defocus precisely locates the far field (exactly where is that far field anyway?).

Harvey JE, Krywonos A, Bogunovic D.

Appl Opt. 2002 May 1;41(13):2586-8.

PMID:
12009170
30.

[Mixed cryoglobulinemia with severe neurologic complications].

Bogunović D, Stojcev S.

Vojnosanit Pregl. 1987 Jul-Aug;44(4):297-9. Serbian. No abstract available.

PMID:
3673010
31.

[Paraplegia within the scope of a conversion neurosis reaction].

Bogunović D, Vucetić V, Umićević P.

Vojnosanit Pregl. 1986 Mar-Apr;43(2):158-9. Serbian. No abstract available.

PMID:
3727460
32.

[Our approach and position on the cessation of anti-epileptic therapy in soldiers admitted for observation for the verification of epilepsy].

Bogunović D, Dordević D, Umićević P, Makević M.

Vojnosanit Pregl. 1985 Mar-Apr;42(2):126-8. Serbian. No abstract available.

PMID:
4024500
33.

[Dissimulation of epilepsy by soldiers].

Umićević P, Dordević D, Bogunović D, Makević M.

Vojnosanit Pregl. 1984 Jul-Aug;41(4):266-8. Serbian. No abstract available.

PMID:
6506552
34.

[Computerized tomography in evaluating the etiology of focal epilepsy].

Bogunović D, Umićević P, Dulić S.

Vojnosanit Pregl. 1984 Jul-Aug;41(4):285-6. Serbian. No abstract available.

PMID:
6438906
35.

[The clinical picture and incidence of psychological disorders in soldiers referred for clinical examination for suspected epilepsy].

Bogunović D, Svićević R, Miljanović B.

Vojnosanit Pregl. 1984 Jan-Feb;41(1):28-30. Serbian. No abstract available.

PMID:
6710903
36.

[Clinical and morphologic characteristics of cysticercosis of the central nervous system].

Dordević D, Umićević P, Mihajlović M, Bogunović D, Dimitrijević J.

Zb Vojnomed Akad. 1983;25:48-52. Croatian. No abstract available.

PMID:
6598251
37.

[Cysticercosis of the central nervous system detected by cerebrospinal fluid examination. Case report].

Umićević P, Dordević D, Berger S, Bogunović D.

Vojnosanit Pregl. 1982 Sep-Oct;39(5):378-80. Serbian. No abstract available.

PMID:
7164354
38.

[Peroneal muscular atrophy. Case report].

Bogunović D, Dordević D.

Vojnosanit Pregl. 1982 Sep-Oct;39(5):376-7. Serbian. No abstract available.

PMID:
7164353
39.

[Comparative analysis of the effects of Redgergin and Trental in patients with cerebral infarct].

Jovicić A, Dordević D, Magdić B, Umicević P, Bogunović D, Makević M.

Vojnosanit Pregl. 1982 Sep-Oct;39(5):357-61. Serbian. No abstract available.

PMID:
7164349
40.

[Treatment of spastic torticollis using short-term analytic orientation therapy].

Bogunović D, Dordević D, Umićević P.

Vojnosanit Pregl. 1982 Mar-Apr;39(2):103-5. Serbian. No abstract available.

PMID:
7113015

Supplemental Content

Loading ...
Support Center